I am a hematologist-oncologist who specializes in the study and treatment of lymphoma. My work focuses on the development of novel therapies for patients with B cell lymphoma, particularly the indolent lymphomas (follicular, marginal zone, small lymphocytic) and Waldenstrom macroglobulinemia, as well as chronic lymphocytic leukemia.
My research interest is in tumor immunology and signal transduction. I am involved in the development of novel therapies that exploit the immune system as a way to treat cancer. I am also interested in developing targeted therapies for lymphoma and in understanding the mechanisms by which these therapies work.
I am also a member of the Waldenstrom Macroglobulinemia Clinical Trial Group.